Grants
Biotechnology company receives grants from NIAID, NIAAA
Published in Vaccine Weekly, October 22nd, 2003
Large Scale Biology Corp. (LSBC) has been awarded a 2-year research grant by the National Institute of Allergy and Infectious Diseases (NIAID) to investigate the potential of LSBC's proprietary plant viral vector technology for producing preventative and therapeutic HIV-1 peptide vaccines. They have also received a grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for research leading to the discovery of biomarkers for alcohol-related diseases.
The HIV peptide vaccine work will be conducted at LSBC's Vacaville, California, facility.
Epitope display on the surface of plant viruses holds significant promise for the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2003-10-22)
More Articles from Vaccine Weekly
- Malaria Vaccine
Lipid metabolism is possible new target for malaria chemotherapy - Smallpox Vaccine
Clonal vaccinia virus grown in cell culture as a new smallpox vaccine - Biomimetics
Biomimetic design in microparticulate vaccines reviewed - Cancer Vaccine
Frontier of tumor vaccines has gone from gene therapy to dendritic cells - Pneumococcal Vaccine
Genetic variation influences the B-cell response to pneumococcal vaccine - Tumor Markers
Tumor antigens and markers in renal cell carcinoma reviewed - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
